White label – Pompe disease - ClinicalTrials.eu

Study on Esketamine and Propofol for Anesthesia in Electroconvulsive Therapy for Patients with Major Depression

Not recruiting

3 1 1 1
Investigated Diseases:
- Major depression
Investigated Drugs:
Study of iberdomide alone or with drug combinations for patients with multiple myeloma: testing safety and effectiveness of different doses

Not recruiting

1 1 1 1
Investigated Diseases:
- Plasma cell myeloma
Investigated Drugs:
Study on Improving Knee Implant Stability in Osteoarthritis Patients Using Denosumab and Zoledronic Acid

Not recruiting

2 1 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
Study on the Safety and Effects of Durvalumab and Tremelimumab with Radiotherapy for Patients with Metastatic Squamous Cell Carcinoma

Not recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
- Durvalumab
- Tremelimumab
Study on Canakinumab for Treating Anemia in Patients with Lower-Risk Myelodysplastic Syndromes or MDS/MPN

Not recruiting

2 1 1 1
Investigated Diseases:
- Anaemia
- Myelodysplastic syndrome
Investigated Drugs:
- Canakinumab
Study on the Effects of Colchicine on Arterial Stiffness in Patients with High Blood Pressure

Not recruiting

2 1 1
Investigated Diseases:
- Arterial stiffness
- Hypertension
Investigated Drugs:
- Colchicine
Study on the Effects of Fordadistrogene Movaparvovec for Patients with Duchenne Muscular Dystrophy

Not recruiting

3 1 1
Investigated Diseases:
- Duchenne muscular dystrophy
Investigated Drugs:
- Eculizumab
Study on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss

Not recruiting

2 1 1
Investigated Diseases:
- Deafness neurosensory
Investigated Drugs:
- 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole
- Prednisolone
Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Not recruiting

3 1 1 1
Investigated Drugs:
- Trastuzumab Deruxtecan
- Trastuzumab Emtansine
+7
Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Not recruiting

3 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Alpelisib
- Fulvestrant
+10

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies